Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider ...

Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to ...

Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...

Biotech company 23andMe had a rough 2024, including a $30 million settlement payment after customer data was compromised.

With clear, enforceable regulations, the potential sale or acquisition of the 23andme data would be far less perilous, ensuring that the benefits of genomic research are achieved without ...

But as many as 7 million accounts may be in the sale — half the users of 23andMe. It is unclear whether whoever compiled the Ashkenazi list — which actually has 999,999 entries — is the same ...

23andMe faced major hurdles in 2024 ... which The Atlantic reported could include the sale of their personal genetic data. Wojcicki walked back her remark in a separate filing.